These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32184119)

  • 41. Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma.
    MacIver CL; Busaidi AA; Ganeshan B; Maynard JA; Wastling S; Hyare H; Brandner S; Markus JE; Lewis MA; Groves AM; Cwynarski K; Thust SC
    J Pers Med; 2021 Aug; 11(9):. PubMed ID: 34575653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma.
    Ceschin R; Kurland BF; Abberbock SR; Ellingson BM; Okada H; Jakacki RI; Pollack IF; Panigrahy A
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2170-6. PubMed ID: 26338910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating drug distribution in children and young adults with diffuse midline glioma of the pons (DIPG) treated with convection-enhanced drug delivery.
    Szychot E; Bhagawati D; Sokolska MJ; Walker D; Gill S; Hyare H
    Front Neuroimaging; 2023; 2():1062493. PubMed ID: 37554653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics.
    Li Q; Dong F; Jiang B; Zhang M
    Front Oncol; 2021; 11():646267. PubMed ID: 34109112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MRI whole-lesion texture analysis on ADC maps for the prognostic assessment of ischemic stroke.
    Zhang Y; Zhuang Y; Ge Y; Wu PY; Zhao J; Wang H; Song B
    BMC Med Imaging; 2022 Jul; 22(1):115. PubMed ID: 35778678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas.
    Pan C; Zhang M; Xiao X; Kong L; Wu Y; Zhao X; Sun T; Zhang P; Geng Y; Zuo P; Wang Y; Li X; Gu G; Li T; Wu Z; Zhang J; Zhang L
    Neurosurg Rev; 2023 Jun; 46(1):151. PubMed ID: 37358632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of Inflammatory Breast Cancer Survival Outcomes Using Computed Tomography-Based Texture Analysis.
    Song SE; Seo BK; Cho KR; Woo OH; Ganeshan B; Kim ES; Cha J
    Front Bioeng Biotechnol; 2021; 9():695305. PubMed ID: 34354986
    [No Abstract]   [Full Text] [Related]  

  • 48. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.
    Wu CC; Jain R; Radmanesh A; Poisson LM; Guo WY; Zagzag D; Snuderl M; Placantonakis DG; Golfinos J; Chi AS
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1814-1820. PubMed ID: 30190259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival prediction in glioblastoma on post-contrast magnetic resonance imaging using filtration based first-order texture analysis: Comparison of multiple machine learning models.
    Priya S; Agarwal A; Ward C; Locke T; Monga V; Bathla G
    Neuroradiol J; 2021 Aug; 34(4):355-362. PubMed ID: 33533273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Real-time drug testing of paediatric diffuse midline glioma to support clinical decision making: The Zurich DIPG/DMG centre experience.
    Mueller T; Laternser S; Guerreiro Stücklin AS; Gerber NU; Mourabit S; Rizo M; Rushing EJ; Kottke R; Grotzer M; Krayenbühl N; Nazarian J; Mueller S
    Eur J Cancer; 2023 Jan; 178():171-179. PubMed ID: 36455411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of
    Tinkle CL; Duncan EC; Doubrovin M; Han Y; Li Y; Kim H; Broniscer A; Snyder SE; Merchant TE; Shulkin BL
    J Nucl Med; 2019 Mar; 60(3):312-319. PubMed ID: 30072503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC).
    Fonseca A; Afzal S; Bowes L; Crooks B; Larouche V; Jabado N; Perreault S; Johnston DL; Zelcer S; Fleming A; Scheinemann K; Silva M; Vanan MI; Mpofu C; Wilson B; Eisenstat DD; Lafay-Cousin L; Hukin J; Hawkins C; Bartels U; Bouffet E
    J Neurooncol; 2020 Aug; 149(1):45-54. PubMed ID: 32632896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry.
    Leach JL; Roebker J; Schafer A; Baugh J; Chaney B; Fuller C; Fouladi M; Lane A; Doughman R; Drissi R; DeWire-Schottmiller M; Ziegler DS; Minturn JE; Hansford JR; Wang SS; Monje-Deisseroth M; Fisher PG; Gottardo NG; Dholaria H; Packer R; Warren K; Leary SES; Goldman S; Bartels U; Hawkins C; Jones BV
    Neuro Oncol; 2020 Nov; 22(11):1647-1657. PubMed ID: 32506137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Machine learning-based quantitative texture analysis of conventional MRI combined with ADC maps for assessment of IDH1 mutation in high-grade gliomas.
    Alis D; Bagcilar O; Senli YD; Yergin M; Isler C; Kocer N; Islak C; Kizilkilic O
    Jpn J Radiol; 2020 Feb; 38(2):135-143. PubMed ID: 31741126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A homogeneous treatment for non-DIPG diffuse midline glioma.
    Schiavello E; Biassoni V; Gattuso G; Podda M; Chiaravalli S; Barretta F; Antonelli M; De Cecco L; Pecori E; Gandola L; Massimino M
    Tumori; 2023 Jun; 109(3):269-275. PubMed ID: 35708347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arterial spin labelling and diffusion-weighted imaging in paediatric brain tumours.
    Hales PW; d'Arco F; Cooper J; Pfeuffer J; Hargrave D; Mankad K; Clark C
    Neuroimage Clin; 2019; 22():101696. PubMed ID: 30735859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MR Imaging Correlates for Molecular and Mutational Analyses in Children with Diffuse Intrinsic Pontine Glioma.
    Jaimes C; Vajapeyam S; Brown D; Kao PC; Ma C; Greenspan L; Gupta N; Goumnerova L; Bandopahayay P; Dubois F; Greenwald NF; Zack T; Shapira O; Beroukhim R; Ligon KL; Chi S; Kieran MW; Wright KD; Poussaint TY
    AJNR Am J Neuroradiol; 2020 May; 41(5):874-881. PubMed ID: 32381545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance.
    De Cecco CN; Ganeshan B; Ciolina M; Rengo M; Meinel FG; Musio D; De Felice F; Raffetto N; Tombolini V; Laghi A
    Invest Radiol; 2015 Apr; 50(4):239-45. PubMed ID: 25501017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Magnetic resonance texture analysis utility in differentiating intraparenchymal neurosarcoidosis from primary central nervous system lymphoma: a preliminary analysis.
    Bathla G; Soni N; Endozo R; Ganeshan B
    Neuroradiol J; 2019 Jun; 32(3):203-209. PubMed ID: 30789057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunotherapy approaches for the treatment of diffuse midline gliomas.
    Bernstock JD; Hoffman SE; Kappel AD; Valdes PA; Essayed W; Klinger NV; Kang KD; Totsch SK; Olsen HE; Schlappi CW; Filipski K; Gessler FA; Baird L; Filbin MG; Hashizume R; Becher OJ; Friedman GK
    Oncoimmunology; 2022; 11(1):2124058. PubMed ID: 36185807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.